Join
Nemaura Medical Inc. logo

NMRD

NASDAQ

Nemaura Medical Inc.

SectorHealth CareIndustryMedical/Dental Instruments
$0.12-0.01 (-5.38%)
News25/Ratings2

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.

Latest news

25 items

NMRD FAQ

6 questions
  • What does Nemaura Medical Inc. do?
    Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.
  • Where does NMRD stock trade?
    Nemaura Medical Inc. (NMRD) is listed on NASDAQ.
  • What sector and industry is NMRD in?
    Nemaura Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.
  • What are analysts saying about NMRD?
    Nemaura Medical Inc. has had 2 recent analyst actions on file. The most recent action was from H.C. Wainwright: Buy with a $1200.00 price target on 2022-03-29. Recent price targets range from $750.00 to $1200.00.
  • What companies are similar to NMRD?
    Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare NMRD side-by-side with any of them on Quantisnow.
  • How can I track NMRD on Quantisnow?
    Quantisnow aggregates Nemaura Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NMRD to receive live email and push alerts on every new disclosure.